1. Home
  2. PCRX vs ADV Comparison

PCRX vs ADV Comparison

Compare PCRX & ADV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • ADV
  • Stock Information
  • Founded
  • PCRX 2006
  • ADV 1987
  • Country
  • PCRX United States
  • ADV United States
  • Employees
  • PCRX N/A
  • ADV N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • ADV Business Services
  • Sector
  • PCRX Health Care
  • ADV Consumer Discretionary
  • Exchange
  • PCRX Nasdaq
  • ADV Nasdaq
  • Market Cap
  • PCRX 1.1B
  • ADV 875.7M
  • IPO Year
  • PCRX 2011
  • ADV N/A
  • Fundamental
  • Price
  • PCRX $24.91
  • ADV $1.49
  • Analyst Decision
  • PCRX Buy
  • ADV Strong Buy
  • Analyst Count
  • PCRX 9
  • ADV 1
  • Target Price
  • PCRX $30.67
  • ADV $3.50
  • AVG Volume (30 Days)
  • PCRX 920.6K
  • ADV 887.0K
  • Earning Date
  • PCRX 05-06-2025
  • ADV 03-07-2025
  • Dividend Yield
  • PCRX N/A
  • ADV N/A
  • EPS Growth
  • PCRX N/A
  • ADV N/A
  • EPS
  • PCRX N/A
  • ADV N/A
  • Revenue
  • PCRX $700,966,000.00
  • ADV $3,566,324,000.00
  • Revenue This Year
  • PCRX $9.77
  • ADV N/A
  • Revenue Next Year
  • PCRX $9.83
  • ADV $7.29
  • P/E Ratio
  • PCRX N/A
  • ADV N/A
  • Revenue Growth
  • PCRX 3.85
  • ADV N/A
  • 52 Week Low
  • PCRX $11.16
  • ADV $1.47
  • 52 Week High
  • PCRX $31.67
  • ADV $4.82
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 55.86
  • ADV 31.23
  • Support Level
  • PCRX $23.93
  • ADV $1.55
  • Resistance Level
  • PCRX $25.08
  • ADV $1.71
  • Average True Range (ATR)
  • PCRX 0.97
  • ADV 0.17
  • MACD
  • PCRX 0.20
  • ADV 0.00
  • Stochastic Oscillator
  • PCRX 76.05
  • ADV 3.64

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About ADV Advantage Solutions Inc.

Advantage Solutions Inc is the provider of outsourced sales and marketing solutions to consumer goods companies and retailers. It has a technology-enabled platform of sales and marketing services like headquarter sales, retail merchandising, in-store sampling, digital commerce, and shopper marketing. For brands and retailers of all sizes, the firm helps to get the right products on the shelf and into the hands of consumers. The company helps its clients to sell more while spending less. Advantage has offices throughout North America and strategic investments in select markets throughout Africa, Asia, Australia, and Europe through which it services the global needs of multinational, regional, and local manufacturers. Its services are provided across two segments sales and marketing.

Share on Social Networks: